Natalie S. Nunnally

461 total citations
15 papers, 340 citations indexed

About

Natalie S. Nunnally is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Natalie S. Nunnally has authored 15 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Epidemiology and 3 papers in Small Animals. Recurrent topics in Natalie S. Nunnally's work include Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (14 papers) and Infectious Diseases and Mycology (3 papers). Natalie S. Nunnally is often cited by papers focused on Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (14 papers) and Infectious Diseases and Mycology (3 papers). Natalie S. Nunnally collaborates with scholars based in United States and Brazil. Natalie S. Nunnally's co-authors include Shawn R. Lockhart, Elizabeth L. Berkow, Kizee A. Etienne, Karlyn D. Beer, David Angulo, Mike Birch, Derek Law, R J Kuykendall, D. Joseph Sexton and Meghan L. Bentz and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Natalie S. Nunnally

15 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie S. Nunnally United States	10	291	198	59	42	31	15	340
Marie-Thérèse Baixench France	5	339 1.2×	210 1.1×	48 0.8×	17 0.4×	72 2.3×	6	390
Mohammad T. Albataineh United States	9	193 0.7×	190 1.0×	61 1.0×	8 0.2×	44 1.4×	13	362
Khaled Alobaid Kuwait	13	317 1.1×	283 1.4×	59 1.0×	20 0.5×	19 0.6×	25	382
Marco Passera Italy	10	189 0.6×	186 0.9×	74 1.3×	24 0.6×	16 0.5×	16	276
Brittany O’Brien United States	5	290 1.0×	239 1.2×	27 0.5×	24 0.6×	27 0.9×	5	346
J. L. Finquelievich Argentina	12	275 0.9×	247 1.2×	58 1.0×	11 0.3×	46 1.5×	34	361
Daniel F. Sheehan United States	6	279 1.0×	242 1.2×	44 0.7×	13 0.3×	14 0.5×	11	363
Mohammad Asadzadeh Kuwait	10	338 1.2×	271 1.4×	42 0.7×	20 0.5×	12 0.4×	24	364
Catiana Dudiuk Argentina	13	404 1.4×	306 1.5×	73 1.2×	6 0.1×	36 1.2×	21	444
Min Gu Kang South Korea	2	361 1.2×	308 1.6×	52 0.9×	23 0.5×	12 0.4×	5	388

Countries citing papers authored by Natalie S. Nunnally

Since Specialization

Citations

This map shows the geographic impact of Natalie S. Nunnally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie S. Nunnally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie S. Nunnally more than expected).

Fields of papers citing papers by Natalie S. Nunnally

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie S. Nunnally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie S. Nunnally. The network helps show where Natalie S. Nunnally may publish in the future.

Co-authorship network of co-authors of Natalie S. Nunnally

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie S. Nunnally. A scholar is included among the top collaborators of Natalie S. Nunnally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie S. Nunnally. Natalie S. Nunnally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gade, Lalitha, Elizabeth Misas, Anastasia P. Litvintseva, et al.. (2024). Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil. Antimicrobial Agents and Chemotherapy. 68(4). e0162023–e0162023. 4 indexed citations

Misas, Elizabeth, Emma E. Seagle, Malavika Rajeev, et al.. (2024). Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates. Journal of Clinical Microbiology. 62(2). e0114023–e0114023. 10 indexed citations

Bentz, Meghan L., Natalie S. Nunnally, Shawn R. Lockhart, et al.. (2024). Evaluation of CHROMagar Candida Plus for the detection of C. auris with a panel of 206 fungal isolates and 83 colonization screening skin-swabs. Microbiology Spectrum. 12(4). e0356423–e0356423. 6 indexed citations

Nunnally, Natalie S., et al.. (2023). In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans. Microbiology Spectrum. 11(1). e0278922–e0278922. 12 indexed citations

Misas, Elizabeth, John Deng, Jeremy A.W. Gold, et al.. (2023). Genomic description of human clinicalAspergillus fumigatusisolates, California, 2020. Medical Mycology. 61(2). 2 indexed citations

Chiller, Tom, Kaitlin Forsberg, Natalie S. Nunnally, et al.. (2022). Fatal Fungicide-Associated Triazole-Resistant Aspergillus fumigatus Infection, Pennsylvania, USA. Emerging infectious diseases. 28(9). 1904–1905. 10 indexed citations

Gold, Jeremy A.W., Stepy Thomas, Lewis Perry, et al.. (2022). Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease—Georgia, United States, 2017–2019. Open Forum Infectious Diseases. 9(7). ofac215–ofac215. 9 indexed citations

Etienne, Kizee A., Elizabeth L. Berkow, Lalitha Gade, et al.. (2021). Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States. mBio. 12(4). e0180321–e0180321. 30 indexed citations

Nunnally, Natalie S., et al.. (2021). Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method. Journal of Clinical Microbiology. 59(4). 6 indexed citations

10.

Bentz, Meghan L., Natalie S. Nunnally, Shawn R. Lockhart, D. Joseph Sexton, & Elizabeth L. Berkow. (2021). Antifungal activity of nikkomycin Z against Candida auris. Journal of Antimicrobial Chemotherapy. 76(6). 1495–1497. 24 indexed citations

11.

Seagle, Emma E., Brendan R. Jackson, Shawn R. Lockhart, et al.. (2021). The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic. Clinical Infectious Diseases. 74(5). 802–811. 98 indexed citations

12.

Nunnally, Natalie S., Eric M. Ransom, Derek Law, et al.. (2021). In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents. Journal of Fungi. 7(5). 378–378. 33 indexed citations

13.

Nunnally, Natalie S., Rory M. Welsh, Milena Kordalewska, et al.. (2020). Performance Evaluation of Culture-Independent SYBR Green Candida auris Quantitative PCR Diagnostics on Anterior Nares Surveillance Swabs. Journal of Clinical Microbiology. 58(9). 7 indexed citations

14.

Nunnally, Natalie S., Kizee A. Etienne, David Angulo, Shawn R. Lockhart, & Elizabeth L. Berkow. (2019). In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations. Antimicrobial Agents and Chemotherapy. 63(11). 47 indexed citations

15.

Berkow, Elizabeth L., et al.. (2018). Detection of TR ₃₄ /L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017. Antimicrobial Agents and Chemotherapy. 62(5). 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact